DJIA 16,501.65 -12.72 -0.08%
NASDAQ 4,126.97 0.00 0.00%
S&P 500 1,875.39 -4.16 -0.22%
market minute promo

Novo Nordisk

NYSE: NVO



company name or ticker
Company Photos
(Click to zoom)

Novo-Nordisk As (NVO): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report

Trade-Ideas: Novo Nordisk A/S (NVO) Is Today's New Lifetime High Stock

Is There Investment Upside In The Future Of Treating Diabetes?

Sanofi SA Looks Like One Of The Better Bargains In Big Pharma

Sanofi's diverse pipeline is a marked contrast to many Big Pharma peers.

Update on Novo Nordisk's Diabetes Pipeline - Analyst Blog

Shire PLC: Time to Panic?

Novo Nordisk Gives anti-NKG2A Rights to Innate - Analyst Blog

Reflections on the Biotech Earnings Bonanza: LLY, NVO, GILD

A look at some of top names in biotech show that the sector is still growing and 2014 could be another banner year.

Can Novo Nordisk (NVO) Continue to Rise? - Tale of the Tape

Eli Lilly & Co.: Cymbalta Sales Slide Begins

Eli Lilly's top selling drug has lost patent protection, making this an important transition year for the company.
See More Articles...